These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3582465)

  • 1. Acute renal effects of oral felodipine in normal man.
    Schmitz A
    Eur J Clin Pharmacol; 1987; 32(1):17-22. PubMed ID: 3582465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal effects of acute and long-term treatment with felodipine in essential hypertension.
    Hulthén UL; Katzman PL
    J Hypertens; 1988 Mar; 6(3):231-7. PubMed ID: 3361121
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of felodipine on renal haemodynamics and tubular sodium handling after single-dose cyclosporin infusion in renal transplant recipients treated with azathioprine and prednisolone.
    Madsen JK; Kornerup HJ; Pedersen EB
    Scand J Clin Lab Invest; 1995 Nov; 55(7):625-33. PubMed ID: 8633187
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute haemodynamic and renal effects of oral felodipine and ramipril in healthy subjects.
    Hasselgren B; Edgar B; Johnsson G; Rönn O
    Eur J Clin Pharmacol; 1993; 45(4):327-32. PubMed ID: 8299664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Haemodynamic and renal effects of felodipine in young and elderly subjects.
    Lernfelt B; Landahl S; Johansson P; Seligman L; Aberg J
    Eur J Clin Pharmacol; 1998 Oct; 54(8):595-601. PubMed ID: 9860145
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of felodipine on renal function and blood pressure in cyclosporin-treated renal transplant recipients during the first three months after transplantation.
    Madsen JK; Sørensen SS; Hansen HE; Pedersen EB
    Nephrol Dial Transplant; 1998 Sep; 13(9):2327-34. PubMed ID: 9761517
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of single and repeated doses of the calcium antagonist felodipine on blood pressure, renal function, electrolytes and water balance, and renin-angiotensin-aldosterone system in hypertensive patients.
    Leonetti G; Gradnik R; Terzoli L; Fruscio M; Rupoli L; Cuspidi C; Sampieri L; Zanchetti A
    J Cardiovasc Pharmacol; 1986; 8(6):1243-8. PubMed ID: 2434753
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetics of felodipine in patients with impaired renal function.
    Edgar B; Regårdh CG; Attman PO; Aurell M; Herlitz H; Johnsson G
    Br J Clin Pharmacol; 1989 Jan; 27(1):67-74. PubMed ID: 2706189
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of felodipine on renal haemodynamics and tubular sodium handling in cyclosporin-treated renal transplant recipients.
    Sørensen SS; Skovbon H; Eiskjaer H; Thomsen K; Pedersen EB
    Nephrol Dial Transplant; 1992; 7(1):69-78. PubMed ID: 1316584
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute renal effects of felodipine in hypertensive patients with kidney disease.
    Huysmans FT; van Hamersvelt HW; Sluiter HE; Wetzels JF; Koene RA
    Kidney Int Suppl; 1992 May; 36():S106-9. PubMed ID: 1614059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of the calcium antagonist felodipine on renal haemodynamics, tubular sodium handling, and blood pressure in cyclosporin-treated dermatological patients.
    Madsen JK; Zachariae H; Pedersen EB
    Nephrol Dial Transplant; 1997 Mar; 12(3):480-4. PubMed ID: 9075128
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement in renal function by felodipine during cyclosporine treatment in acute and short-term studies.
    Pedersen EB; Madsen JK; Sørensen SS; Zachariae H
    Kidney Int Suppl; 1996 Jun; 55():S94-6. PubMed ID: 8743522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Felodipine in combination with a beta-blocker and a diuretic in chronic treatment of patients with refractory primary hypertension.
    Andersson OK; Hedner T; Granérus G
    Drugs; 1987; 34 Suppl 3():156-60. PubMed ID: 2894974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction between cyclosporine and felodipine in renal transplant recipients.
    Pedersen EB; Sørensen SS; Eiskjaer H; Skovbon H; Thomsen K
    Kidney Int Suppl; 1992 May; 36():S82-6. PubMed ID: 1614074
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The natriuretic effect of the dihydropyridine calcium antagonist felodipine: a placebo-controlled study involving intravenous angiotensin II in normotensive volunteers.
    Sluiter HE; Wetzels JF; Huysmans FT; Koene RA
    J Cardiovasc Pharmacol; 1987; 10 Suppl 10():S154-61. PubMed ID: 2455121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitrendipine and amlodipine mimic the acute effects of enalapril on renal haemodynamics and reduce glomerular hyperfiltration in patients with chronic kidney disease.
    Morrone LF; Ramunni A; Fassianos E; Saracino A; Coratelli P; Passavanti G
    J Hum Hypertens; 2003 Jul; 17(7):487-93. PubMed ID: 12821956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acute and steady-state pharmacokinetics and antihypertensive effects of felodipine in patients with normal and impaired renal function.
    Larsson R; Karlberg BE; Gelin A; Aberg J; Regårdh CG
    J Clin Pharmacol; 1990 Nov; 30(11):1020-30. PubMed ID: 2243149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of systemic NO synthesis inhibition on RPF, GFR, UNa, and vasoactive hormones in healthy humans.
    Bech JN; Nielsen CB; Pedersen EB
    Am J Physiol; 1996 May; 270(5 Pt 2):F845-51. PubMed ID: 8928847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic and pharmacodynamic studies of felodipine in healthy subjects after various single, oral and intravenous doses.
    Edgar B; Regårdh CG; Lundborg P; Romare S; Nyberg G; Rönn O
    Biopharm Drug Dispos; 1987; 8(3):235-48. PubMed ID: 3593901
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.